Skip to main content
Log in

High prevalence of breast cancer in patients with benign thyroid diseases

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: In patients with breast cancer (BC) a high prevalence of benign thyroid diseases (BTD) has been described, Hashimoto’s thyroiditis accounting to a large extent for this association. The aim of this study was to evaluate the prevalence of BC in a large group of patients with BTD. Patients: Clinical records of 622 consecutive patients with BTD were examined. BC prevalence in BTD patients was compared with BC frequency in general population living in the same country. Results: BC prevalence in patients with BTD (38/622; 6.11%) was significantly higher (p=0.0002) compared to BC frequency in general population (2.07%). When patients were divided according to the age of menopause, in females older than 49 yr BC frequency in BTD was significantly higher than in age-matched population (7.6 vs 3.3%; p=0.006), while in females aged 30–49 yr BC frequency in BTD was higher, but not statistically significantly, than in age-matched population (3.7 vs 0.5%; p=0.06). No significant difference in BC prevalence was found when patients were grouped according to the diagnosis of thyroid disorders: Graves’ disease, Hashimoto’s thyroiditis, nodular goiter associated or not associated with serum thyroid autoantibodies (TAb). No significant difference in BC frequency was observed between TAb+ (26/377; 6.9%) and TAb- (12/245; 4.9%) patients. The distribution of known risk factors for breast malignancies was similar in patients with or without BC. Conclusion: In patients with BTD the prevalence of BC is significantly higher than the expected, showing the usefulness of screening for breast malignancy of patients with BTD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chalstrey LJ, Benjamin B. High incidence of breast cancer in thyroid cancer patients. Br J Cancer 1966, 20: 670–5.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. Myhill J, Reeve TS, Hales IB. Thyroid function in breast cancer. Acta Endocrinol (Copenh) 1966, 51: 290–300.

    CAS  Google Scholar 

  3. Sicher K, Waterhouse JA. Thyroid activity in relation to prognosis in mammary cancer. Br J Cancer 1967, 21: 512–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Goldman MB. Thyroid diseases and breast cancer. Epidemiol Rev 1990, 12: 16–28.

    PubMed  CAS  Google Scholar 

  5. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990, 50: 2283–9.

    PubMed  CAS  Google Scholar 

  6. Smyth PP. Thyroid disease and breast cancer. J Endocrinol Invest 1993, 16: 396–401.

    Article  PubMed  CAS  Google Scholar 

  7. Turken O, Narln Y, Demlrbas S, et al. Breast cancer in association with thyroid disorders. Breast Cancer Res 2003, 5: R110–3.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Mittra I, Perrin J, Kumaoka S. Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J 1976, 1: 257–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Ito K, Maruchi N. Breast cancer in patients with Hashimoto’s thyroiditis. Lancet 1975, 2: 1119–21.

    Article  PubMed  CAS  Google Scholar 

  10. Rasmusson B, Feldt-Rasmussen U, Hegedüs L, Perrild H, Bech K, Høier-Madsen M. Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 1987, 23: 553–6.

    Article  PubMed  CAS  Google Scholar 

  11. Maruchi N, Annegers JF, Kurland LT. Hashimoto’s thyroiditis and breast cancer. Mayo Clin Proc 1976, 51: 263–5.

    PubMed  CAS  Google Scholar 

  12. Giani C, Fierabracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996, 81: 990–4.

    PubMed  CAS  Google Scholar 

  13. Giustarini E, Pinchera A, Fierabracci P, et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006, 154: 645–9.

    Article  PubMed  CAS  Google Scholar 

  14. Fiore E, Giustarini E, Mammoli C, et al. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer. J Endocrinol Invest 2007, 30: 734–8.

    Article  PubMed  CAS  Google Scholar 

  15. Garner CN, Ganetzky R, Brainard J, et al. Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery 2007, 142: 806–13.

    Article  PubMed  Google Scholar 

  16. Sioka C, Fotopoulos A. Association of thyroid cancer with breast cancer. Surgery 2009, 145: 123–4.

    Article  PubMed  Google Scholar 

  17. Agarwal DP, Soni TP, Sharma OP, Sharma S. Synchronous malignancies of breast and thyroid gland: a case report and review of literature. J Cancer Res Ther 2007, 3: 172–3.

    Article  PubMed  Google Scholar 

  18. Weiss HA, Brinton LA, Potischman NA, et al. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999, 28: 816–23.

    Article  PubMed  CAS  Google Scholar 

  19. Simon MS, Tang MT, Bernstein L, et al. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 2002, 11: 1574–8.

    PubMed  Google Scholar 

  20. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993, 22: 1000–9.

    Article  PubMed  CAS  Google Scholar 

  21. De Angelis R, Grande E, Inghelmann R, et al. Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 2007, 93: 392–7.

    PubMed  Google Scholar 

  22. Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P. Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest 2001, 24: 763–9.

    Article  PubMed  CAS  Google Scholar 

  23. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 1991, 72: 209–13.

    Article  PubMed  CAS  Google Scholar 

  24. Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999, 84: 561–6.

    PubMed  CAS  Google Scholar 

  25. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000, 6: 871–8.

    Article  PubMed  CAS  Google Scholar 

  26. Stoddard FR 2nd, Brooks AD, Eskin BA, Johannes GJ. Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine. Int J Med Sci 2008, 5: 189–96.

    Article  PubMed  CAS  Google Scholar 

  27. Bonacci R, Pinchera A, Fierabracci P, Gigliotti A, Grasso L, Giani C. Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue. J Endocrinol Invest 1996, 19: 159–64.

    Article  PubMed  CAS  Google Scholar 

  28. Giani C, Campani D, De Negri F, et al. Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue. J Endocrinol Invest 1993, 16: 37–43

    Article  PubMed  CAS  Google Scholar 

  29. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001, 86: 1072–7.

    PubMed  CAS  Google Scholar 

  30. Rajoria S, Suriano R, Shanmugam A, et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010, 20: 33–41.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  31. Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 2007, 109: 1972–9.

    Article  PubMed  CAS  Google Scholar 

  32. Holm LE, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991, 83: 1072–7.

    Article  PubMed  CAS  Google Scholar 

  33. Hoffman DA, McConahey WM, Fraumeni JF Jr, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982, 11: 218–24.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Muller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muller, I., Pinchera, A., Fiore, E. et al. High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34, 349–352 (2011). https://doi.org/10.1007/BF03347458

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347458

Key-words

Navigation